芪苈强心减轻阿霉素诱导的小鼠心脏损伤  

Qiliqiangxin attenuates doxorubicin induced cardiac dysfunction in mice

作　　者：武晓栋 姜惠敏 姚文明[1] 高蓉蓉[1] 李新立[1] WU Xiaodong;JIANG Huirnin;YAO Wenrning;GAO Rongrong;LI Xinli(Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China;Clinical Laboratory Center, Beijing Hospital of Traditional Chinese Medicine, Beijing 100010, China)

机构地区：[1]南京医科大学第一附属医院心脏内科,南京210029 [2]首都医科大学附属北京中医医院检验科,北京100010

出　　处：《上海大学学报（自然科学版）》2018年第2期192-197,共6页Journal of Shanghai University:Natural Science Edition

基　　金：国家自然科学基金青年基金资助项目(81503283);国家自然科学基金重点资助项目(81730106)

摘　　要：探讨了芪苈强心(Qiliqiangxin,QLQX)对阿霉素(doxorubicin,DOX)诱导的小鼠心功能下降的治疗作用.选取7~9周雄性小鼠为实验对象,将其随机分组,通过每周腹腔注射一次阿霉素(4 mg/kg)构建小鼠心脏损伤模型,治疗组同时口饲芪苈强心(0.5 g/(kg·d)).实验终点进行心脏超声检查.实验结果表明,芪苈强心可以减轻阿霉素诱导的心脏损伤,保护小鼠心功能.这提示芪苈强心有可能作为一种缓解阿霉素所致心脏损伤的药物.To investigate the therapeutic effects of Qiliqiangxin（QLQX） in doxorubicin（DOX）-induced cardiac dysfunction in vivo. Male mice aged 7~9 weeks were randomly divided into several groups. DOX（4 mg/kg） was injected to induce cardiotoxicity via intraperitoneal administration weekly, and QLQX was given by gavage every day for4 weeks at a dose of 0.5 g/（kg·d）. After 4 weeks, echocardiography was performed to detect the cardiac function and it was showed that cardiac function could be significantly improved in mice treated with QLQX versus the saline. These findings indicated that QLQX could function as an intervening treatment for the patients who were treated with DOX.

关 键 词：芪苈强心 阿霉素 心脏毒性 线粒体 

分 类 号：R541[医药卫生—心血管疾病]